Fredun Pharma

Part of MojoOne Strategy

Market Cap: Micro Cap
Industry: Pharmaceuticals & Biotechnology
ISIN: INE194R01017
NSEID:
BSEID: 539730
View on BSE

INR

1,715.00

28.7 (1.7%)

BSENSE

Mar 24

BSE+NSE Vol: 8.96 k

Access older stock analysis version

{
  "main_header": {
    "sid": 1002605,
    "name": "Fredun Pharma",
    "stock_name": "Fredun Pharma",
    "full_name": "Fredun Pharmaceuticals Ltd",
    "name_url": "stocks-analysis/fredun-pharma",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 0,
    "country_id": 34,
    "currency": "INR",
    "cmp": "1,715.00",
    "chg": 28.7,
    "chgp": "1.7%",
    "dir": 1,
    "prev_price": "1,686.30",
    "mcapval": "920.27 Cr",
    "mcap": "Micro Cap",
    "scripcode": 539730,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE194R01017",
    "curr_date": "Mar 24",
    "curr_time": "",
    "bse_nse_vol": "8.96 k",
    "exc_status": "Active",
    "traded_date": "Mar 24, 2026",
    "traded_date_str": "2026 03 24",
    "score": "",
    "scoreText": "",
    "Live": 1,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/fredun-pharma-1002605-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "text": "Part of MojoOne Strategy",
      "type": "MN",
      "url": "https://www.marketsmojo.com/mojopro/strategy/2",
      "ismore": 0,
      "all_data": [],
      "is_blur": 1,
      "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/fredun-pharma-1002605-0&utm_source=Spage_Score_PartofStrategies"
    }
  },
  "news": {
    "results": [
      {
        "title": "Fredun Pharmaceuticals Ltd: Valuation Shifts Signal Changing Price Attractiveness",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/fredun-pharmaceuticals-ltd-valuation-shifts-signal-changing-price-attractiveness-3909094",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/FredunPharmaceu_valuationdot_3909094.png",
        "date": "2026-03-24 08:01:54",
        "description": "Fredun Pharmaceuticals Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has witnessed a notable shift in its valuation parameters, moving from an attractive to a fair rating. Despite this recalibration, the company continues to outperform the broader market, delivering impressive returns over multiple time horizons, signalling sustained investor interest amid evolving market dynamics."
      },
      {
        "title": "Fredun Pharmaceuticals Ltd Shows Bullish Momentum Amid Technical Upgrades",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/fredun-pharmaceuticals-ltd-shows-bullish-momentum-amid-technical-upgrades-3906318",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/FredunPharmaceu_technicaldot_3906318.png",
        "date": "2026-03-23 08:02:15",
        "description": "Fredun Pharmaceuticals Ltd has demonstrated a notable shift in price momentum, supported by a series of bullish technical indicators and an upgrade in its Mojo Grade from Hold to Buy. The micro-cap pharmaceutical company’s shares have gained 2.61% today, closing at ₹1,662.00, reflecting renewed investor confidence amid improving technical trends and strong relative performance against the broader market."
      },
      {
        "title": "Fredun Pharmaceuticals Ltd is Rated Buy",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/fredun-pharmaceuticals-ltd-is-rated-buy-3900057",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/FredunPharmaceu_mojoScore_3900057.png",
        "date": "2026-03-19 10:10:49",
        "description": "Fredun Pharmaceuticals Ltd is rated Buy by MarketsMOJO, with this rating last updated on 29 July 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 19 March 2026, providing investors with an up-to-date perspective on the company’s performance and outlook."
      },
      {
        "title": "Fredun Pharmaceuticals Ltd: Technical Momentum Shifts Amid Mixed Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/fredun-pharmaceuticals-ltd-technical-momentum-shifts-amid-mixed-signals-3892763",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/FredunPharmaceu_technicaldot_3892763.png",
        "date": "2026-03-16 08:02:42",
        "description": "Fredun Pharmaceuticals Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a nuanced shift in its technical momentum, reflecting a blend of bullish and bearish signals across key indicators. Despite a modest dip of 1.79% on 16 Mar 2026, the stock’s long-term performance remains robust, with a 1-year return of 143.07% significantly outpacing the Sensex’s 1.00% over the same period."
      },
      {
        "title": "Fredun Pharmaceuticals Ltd Shows Strong Technical Momentum Amid Market Volatility",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/fredun-pharmaceuticals-ltd-shows-strong-technical-momentum-amid-market-volatility-3884414",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/FredunPharmaceu_technicaldot_3884414.png",
        "date": "2026-03-11 08:03:23",
        "description": "Fredun Pharmaceuticals Ltd has demonstrated a significant shift in price momentum, supported by a range of technical indicators signalling a bullish trend. With a notable 7.18% gain on the day and a recent upgrade from Hold to Buy by MarketsMOJO, the stock is attracting renewed investor interest amid a strong performance relative to the broader market."
      },
      {
        "title": "Fredun Pharmaceuticals Ltd is Rated Buy",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/fredun-pharmaceuticals-ltd-is-rated-buy-3878603",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/FredunPharmaceu_mojoScore_3878603.png",
        "date": "2026-03-08 10:10:38",
        "description": "Fredun Pharmaceuticals Ltd is rated 'Buy' by MarketsMOJO, with this rating last updated on 29 July 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 09 March 2026, providing investors with the latest insights into its performance and outlook."
      },
      {
        "title": "Fredun Pharmaceuticals Ltd is Rated Buy",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/fredun-pharmaceuticals-ltd-is-rated-buy-3855096",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/FredunPharmaceu_mojoScore_3855096.png",
        "date": "2026-02-25 10:11:10",
        "description": "Fredun Pharmaceuticals Ltd is rated 'Buy' by MarketsMOJO, with this rating last updated on 29 July 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 25 February 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing."
      },
      {
        "title": "Fredun Pharmaceuticals Ltd Sees Technical Momentum Shift Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/fredun-pharmaceuticals-ltd-sees-technical-momentum-shift-amid-mixed-market-signals-3843579",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/FredunPharmaceu_technicaldot_3843579.png",
        "date": "2026-02-17 08:06:06",
        "description": "Fredun Pharmaceuticals Ltd has experienced a notable shift in its technical parameters, reflecting a nuanced change in price momentum. Despite a recent decline in daily price, the stock maintains a bullish stance on several key moving averages and monthly indicators, signalling potential opportunities for investors amid a complex technical landscape."
      },
      {
        "title": "Fredun Pharmaceuticals Gains 10.32%: 2 Key Factors Driving the Rally",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/fredun-pharmaceuticals-gains-1032-2-key-factors-driving-the-rally-3839416",
        "imagepath": "",
        "date": "2026-02-14 12:06:12",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>9 Feb:</strong> Q3 FY26 results reveal margin expansion and stellar profit growth</p>\n                    <p><strong>12 Feb:</strong> Valuation shifts signal changing price attractiveness</p>\n                    <p><strong>13 Feb:</strong> Week closes at ₹1,818.05 (+10.32% weekly gain)</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">₹1,796.60</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">₹1,818.05</div><div class=\"stat-change positive\">+10.32%</div></div>\n                    <div class..."
      }
    ],
    "total": 228,
    "sid": "1002605",
    "stock_news_url": "https://www.marketsmojo.com/news/fredun-pharmaceuticals-1002605"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
      "datetime": "21-Mar-2026",
      "details": "Intimation of Investor/Analyst Meeting under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Meeting Updates",
      "datetime": "16-Mar-2026",
      "details": "Intimation On Investor Meeting under reg 30 of SEBI (LODR) Reg 2015 on 18th March 2026.",
      "source": "BSE"
    },
    {
      "caption": "Analyst/Institutional Investors Meeting Held On Wednesday 11Th March 2026 Organised By Arihant Capital - Bharat Connect Conference Rising Star 2026.",
      "datetime": "12-Mar-2026",
      "details": "Analyst/Institutional Investors meeting held on Wednesday 11th March 2026 organised by Arihant Capital - Bharat Connect Conference Rising Star 2026.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Fredun Pharmaceuticals Ltd has declared <strong>7%</strong> dividend, ex-date: 23 Sep 25",
          "dt": "2025-09-23",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Fredun Pharmaceuticals Ltd: Valuation Shifts Signal Changing Price Attractiveness

2026-03-24 08:01:54

Fredun Pharmaceuticals Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has witnessed a notable shift in its valuation parameters, moving from an attractive to a fair rating. Despite this recalibration, the company continues to outperform the broader market, delivering impressive returns over multiple time horizons, signalling sustained investor interest amid evolving market dynamics.

Read full news article

Fredun Pharmaceuticals Ltd Shows Bullish Momentum Amid Technical Upgrades

2026-03-23 08:02:15

Fredun Pharmaceuticals Ltd has demonstrated a notable shift in price momentum, supported by a series of bullish technical indicators and an upgrade in its Mojo Grade from Hold to Buy. The micro-cap pharmaceutical company’s shares have gained 2.61% today, closing at ₹1,662.00, reflecting renewed investor confidence amid improving technical trends and strong relative performance against the broader market.

Read full news article

Fredun Pharmaceuticals Ltd is Rated Buy

2026-03-19 10:10:49

Fredun Pharmaceuticals Ltd is rated Buy by MarketsMOJO, with this rating last updated on 29 July 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 19 March 2026, providing investors with an up-to-date perspective on the company’s performance and outlook.

Read full news article

Fredun Pharmaceuticals Ltd: Technical Momentum Shifts Amid Mixed Signals

2026-03-16 08:02:42

Fredun Pharmaceuticals Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a nuanced shift in its technical momentum, reflecting a blend of bullish and bearish signals across key indicators. Despite a modest dip of 1.79% on 16 Mar 2026, the stock’s long-term performance remains robust, with a 1-year return of 143.07% significantly outpacing the Sensex’s 1.00% over the same period.

Read full news article

Fredun Pharmaceuticals Ltd Shows Strong Technical Momentum Amid Market Volatility

2026-03-11 08:03:23

Fredun Pharmaceuticals Ltd has demonstrated a significant shift in price momentum, supported by a range of technical indicators signalling a bullish trend. With a notable 7.18% gain on the day and a recent upgrade from Hold to Buy by MarketsMOJO, the stock is attracting renewed investor interest amid a strong performance relative to the broader market.

Read full news article

Fredun Pharmaceuticals Ltd is Rated Buy

2026-03-08 10:10:38

Fredun Pharmaceuticals Ltd is rated 'Buy' by MarketsMOJO, with this rating last updated on 29 July 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 09 March 2026, providing investors with the latest insights into its performance and outlook.

Read full news article

Fredun Pharmaceuticals Ltd is Rated Buy

2026-02-25 10:11:10

Fredun Pharmaceuticals Ltd is rated 'Buy' by MarketsMOJO, with this rating last updated on 29 July 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 25 February 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing.

Read full news article

Fredun Pharmaceuticals Ltd Sees Technical Momentum Shift Amid Mixed Market Signals

2026-02-17 08:06:06

Fredun Pharmaceuticals Ltd has experienced a notable shift in its technical parameters, reflecting a nuanced change in price momentum. Despite a recent decline in daily price, the stock maintains a bullish stance on several key moving averages and monthly indicators, signalling potential opportunities for investors amid a complex technical landscape.